Funding for this research was provided by:
H2020 Marie Skłodowska-Curie Actions (813196)
Received: 27 October 2022
Accepted: 23 November 2022
First Online: 5 December 2022
: Zamora Health Area Medication Research Ethics Committee approved the research protocol under registration number 574. The foreseeable risks and inconveniences of the research are acceptable of the expected benefits. The planned procedure for information and obtaining informed consent is considered adequate. Participants and their next to kin will be requested to sign an informed consent form before the study begins.
: Not applicable.
: No competing interest was declared.